AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 61-80 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
61
Isar Aerospace
mediummedium
Opp 5
Risk 4

Thesis: Isar Aerospace has the clearest recent opportunity setup in this screen: a June 2026 article summary says it raised €270 million ($312 million), has total capital near €1 billion excluding ESA support, and scheduled a Spectrum launch window for June 15-21 from Norway. If execution succeeds, the article frames it as a milestone for European commercial launch capability.

Why now: Recent supporting article context within the recent evidence window supports timing: is dated June 9, 2026 and states Isar raised €270 million and had a June 15-21 Spectrum launch window from Andoya. Date basis is source date.

Evidence
  • The article summary says Isar raised €270 million ($312 million), total capital is near €1 billion excluding ESA support, and the second Spectrum launch was scheduled for June 15-21 from Norway’s Andoya spaceport. pulse.bot
  • The same summary makes the thesis dependent on launch execution, noting success would make Isar the first European commercial startup to reach orbit, implying material milestone risk if unsuccessful. pulse.bot

Caveats: Evidence is supporting article context only and appears under weak context, not direct dated events. Positive and risk interpretations come from the same article and are not independent confirmation.

62
K2 Space
mediummedium
Opp 5
Risk 2

Thesis: K2 Space has a credible 1 year+ opportunity setup because a dated June 11, 2026 article says it landed a key supplier role in the U.S. Space Force's next-generation military communications network and will provide the satellite platform for SES's PTS-G program, which could support longer-cycle strategic relevance and follow-on demand if execution proceeds.

Why now: The evidence is recent within the 90-day recent evidence window and dated June 11, 2026 on a source date basis, which fits a 1 year+ horizon because supplier-role wins in defense satcom can matter over a longer program cycle if they convert into execution and revenue-bearing milestones.

Evidence
  • June 11, 2026: SpaceNews summary says K2 Space and Rocket Lab 'have landed key supplier roles' in the U.S. Space Force's next-generation military communications network, and K2 Space 'will provide the satellite platform for SES’s entry' in PTS-G. spacenews.com

Caveats: Available support is supporting article context with neutral polarity, not direct structured positive event/fact evidence. Only one dated article remains within the recent evidence window; same-article repeated rows are not independent confirmation.

63
Millennium Space Systems
mediummedium
Opp 5
Risk 4

Thesis: Millennium Space Systems has a positive long-horizon signal from being named among companies awarded Space Force Andromeda contracts tied to geosynchronous reconnaissance and surveillance satellites, indicating program access in a strategically relevant segment.

Why now: The relevant evidence is within the recent evidence window: an April 8, 2026 article said the U.S. Space Force awarded 14 companies more than $1.8 billion in Andromeda contracts and included Boeing's Millennium Space Systems, which is potentially durable over a 1 year+ horizon if tasking converts into meaningful work

Evidence
  • U.S. Space Force's SSC awarded 14 companies more than $1.8 billion in firm fixed price Andromeda contracts; the companies include Boeing's Millennium Space Systems. defensedaily.com

Caveats: Evidence is supporting article context, not a company-specific contract award document or structured positive event row. Reviewed evidence does not show Millennium's individual award size or share of the ceiling value. Same article repeated in weak-context rows is not independent confirmation.

64
Northwood Space
mediumweak
Opp 5
Risk 2

Thesis: Northwood Space has the clearest reviewed sources-supported opportunity among the smaller private names because the reviewed sources directly says it has a Space Force contract and a factory tied to optical ground stations, which supports durable government-linked space infrastructure relevance over a 1 year+ horizon.

Why now: The reviewed sources' membership rationale explicitly anchors current relevance to a Space Force contract and factory buildout tied to optical ground stations, citing article, though the article is not supplied in the reviewed sources.

Caveats: No representative article object or is included despite the cited article ID. Single-article support limits conviction.

65
Orion Space Solutions
mediummedium
Opp 5
Risk 2

Thesis: Orion Space Solutions has meaningful contract-backed business activity within the recent evidence window, with initial contracts over $24 million, over 25 payloads, multi-year execution scope, and total potential value above $100 million if batch deliveries complete.

Why now: A representative article dated March 29, 2026 states Orion Space Solutions won initial contracts worth over $24 million to build more than 25 advanced payloads, with total potential value over $100 million and multi-year design, manufacturing, testing, and calibration work, which can matter over a 1 year+ horizon

Evidence
  • Arcfield’s Orion Space Solutions secured initial contracts worth over $24 million to build over 25 advanced payloads for an undisclosed space customer, with total potential contract value over $100 million as batch deliveries are completed; work spans design, manufacturing, testing and calibration over multiple years. Dated March 29, 2026. washingtonexec.com

Caveats: This is supporting article context and explicitly weaker than direct structured company-event evidence. The customer is undisclosed. Only one article is retained; same-article repetition is not independent confirmation.

66
OroraTech
mediummedium
Opp 5
Risk 2

Thesis: OroraTech shows moderate long-horizon opportunity because a dated May 4, 2026 article reports deployment of four proprietary wildfire-detection satellites for Greece as part of an operational sovereign system, suggesting real product deployment, country-level adoption, and vertically integrated execution from satellites through data processing.

Why now: A dated article with May 4, 2026 states that four satellites in the Hellenic Fire System launched and deployed on May 3, making Greece the first country with a sovereign operational wildfire-detection constellation; for a 1 year+ horizon, that kind of operational deployment can matter as a proof point for follow-on adoption if it persists

Evidence
  • Published May 4, 2026: Four OroraTech satellites that are part of the Hellenic Fire System launched and deployed on May 3; the mission makes Greece the first country to deploy a sovereign operational constellation dedicated specifically to wildfire detection. spacenews.com
  • The system consists of four proprietary OroraTech Forest satellites equipped with thermal infrared cameras, a ground station in Greece, and OroraTech's Wildfire Solution platform integrated into emergency services programs. spacenews.com

Caveats: The available evidence is weak context/supporting article context, not stronger company-specific events. Same article supplies the key claims, so this is not independent confirmation. No material adverse evidence is available, but absence of risk evidence is not proof of low risk.

67
RapidTek
lowweak
Opp 5
Risk 3

Thesis: Relatively better opportunity within these reviewed sources: the membership rationale says RapidTek successfully connected its Black Kite-2 8U CubeSat with ground stations and aims for a LEO IoT network. That is a concrete technical milestone with a plausible 1 year+ commercialization pathway if network development continues.

Why now: Why now is the reported successful satellite-ground connection and stated LEO IoT ambition referenced in article ID, though the reviewed sources does not include the article or exact timing details.

Caveats: The technical milestone is described only in membership rationale, not available direct evidence. Article ID has no in the reviewed sources. Technical connectivity milestone is weaker than contracted commercial deployment.

68
Skyroot Aerospace
mediummedium
Opp 5
Risk 4

Thesis: Skyroot has a credible long-horizon opportunity case from recent financing and launcher milestone positioning: Fortune India says it raised nearly $60 million at a $1.1 billion pre-money valuation and is preparing for the maiden flight of Vikram-1, its orbital launch vehicle.

Why now: The relevant dated development is the reported financing on May 7, 2026 alongside the stated approach to the Vikram-1 maiden flight, which fits a 1 year+ thesis if execution progresses.

Evidence
  • Fortune India says Skyroot raised nearly $60 million on May 7, 2026 at a $1.1 billion pre-money valuation and is preparing for the maiden flight of Vikram-1. fortuneindia.com

Caveats: Support is supporting article context only; the reviewed sources have no direct positive events available for Skyroot. Same-article repeated context rows are not independent confirmation.

69
Spark Space
mediummedium
Opp 5
Risk 5

Thesis: Spark Space has a credible speculative opportunity because supporting article context says it tested an engine and raised funds for an electric-pump rocket, which are relevant proof points for an early launch company over a 1 year+ horizon.

Why now: The reviewed sources retains undated evidence indicating Spark Space tested its engine and raised funds for an electric-pump rocket, but the article has no publication timestamp, so recency-sensitive claims should be treated cautiously.

Evidence
  • Chinese startup developing electric-pump rocket; raised funds and tested engine. spacenews.com

Caveats: Article is undated, so business-state recency is uncertain. Evidence is supporting article context, not direct dated event/facts. Same article appears twice in weak-context rows and is not independent confirmation.

70
Stellar Alpina AG
lowweak
Opp 5
Risk 4

Thesis: The reviewed sources' membership rationale states Stellar Alpina is a Swiss space startup that raised CHF 3.5M pre-seed and is developing rotating detonation rocket engines for in-space mobility. For a 1 year+ horizon, recent financing plus differentiated propulsion development creates meaningful upside optionality.

Why now: Why now is relatively better than peers because the rationale includes a recent capital raise and a specific product focus, both of which can influence a 1 year+ strategic trajectory, though no direct dated evidence are available to verify recency sequencing.

Caveats: Membership rationale cites article IDs: and: but no are present. The reviewed sources contain no direct positive or negative evidence arrays despite the financing statement in the rationale. Early-stage propulsion development is inherently high-uncertainty, but that is inferred from stage and product type, not from a available adverse article.

71
The Exploration Company
lowweak
Opp 5
Risk 2

Thesis: Moderate long-horizon opportunity based on article-context evidence that the company won an ESA cargo return service contract and was ranked first in the competition, which suggests external validation and potential programmatic traction if still current.

Why now: Why now is weak: the only cited catalyst is an undated article stating the company won an ESA cargo contract, and the reviewed sources provide no newer dated confirmation within the 90-day window. Recency-sensitive conclusions should therefore be cautious.

Evidence
  • The Exploration Company was contracted by the European Space Agency to develop a Low Earth Orbit cargo return service, and the article says it was ranked first and awarded the contract. tech.eu

Caveats: Only undated article-context evidence is present; no direct structured positive event/facts survived. The reviewed sources includes no within the recent evidence window dated follow-up on financing, program execution, or milestone delivery. Article-level context is weaker than direct company event/fact evidence.

72
Tomorrow.io
lowweak
Opp 5
Risk 4

Thesis: The reviewed sources membership rationale states Tomorrow.io raised an additional $35M, bringing its Series F to $210M, for the DeepSky AI-native satellite constellation, which supports a moderate long-horizon opportunity thesis around financing-backed constellation buildout and commercialization.

Why now: The 'why now' is the capital raise described in the reviewed sources' membership rationale via article: but the ranking payload does not include the article or a richer reviewed evidence row, so recency and detail are only partially grounded.

Evidence
  • Phase-2 membership rationale says Tomorrow.io raised an additional $35M, bringing Series F to $210M, for its DeepSky AI-native satellite constellation.

Caveats: The reviewed sources does not provide the article for the cited membership-support article. This is mainly a financing-backed opportunity thesis, not a contract- or revenue-backed one in these reviewed sources.

73
Transcelestial
lowweak
Opp 5
Risk 4

Thesis: The reviewed sources membership rationale describes Transcelestial as a private lasercom startup aiming for a LEO constellation and having a partnership to advance optical communications architecture in LEO. If current, that supports a durable 1 year+ opportunity tied to optical communications buildout.

Why now: Why now is only moderate because the membership rationale references support references including, and: but the reviewed sources does not provide or article summaries for them. Without visible dated article detail, the near-current business state cannot be confirmed.

Caveats: Important claims appear only in the membership rationale; no -bearing direct evidence is exposed. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0.

74
Umbra
mediummedium
Opp 5
Risk 2

Thesis: Umbra has a moderate long-horizon opportunity case because a dated June 22, 2026 article describes it as a U.S. commercial space company developing and operating a SAR satellite constellation that delivers rapid, regular, high-resolution data to public and private customers, suggesting an already-operational capability base that could support durable growth over a 1 year+ horizon.

Why now: The most recent dated context is June 22, 2026, which is within the 90-day recent evidence window and indicates Umbra currently operates a SAR constellation and serves government and commercial customers. However, no nearer-term catalyst row is available, so the timing case is moderate rather than strong.

Evidence
  • Published June 22, 2026: Umbra is described as a U.S. commercial space company developing and operating a SAR satellite constellation that delivers rapid, regular, and high-resolution data to public and private customers. eoportal.org

Caveats: Evidence is supporting article context/weak context only, not a direct structured positive event row. The July 31, 2024 Umbra article is outside the 90-day dated recent evidence window and was dropped for recency-sensitive scoring.

75
Unastella
lowweak
Opp 5
Risk 4

Thesis: The reviewed sources say Unastella is a South Korean startup developing small satellite launch vehicles, has raised a Series B, and successfully launched Una Express-I. That combination of financing and a successful launch milestone is one of the clearer long-horizon opportunity setups in this screen, if current.

Why now: Why now is relatively stronger because the rationale includes both funding and a technical milestone, which are durable indicators for a 1 year+ horizon, though exact dates and chronology cannot be checked from the reviewed sources' empty post-recent evidence window evidence tables.

Caveats: Membership rationale cites article IDs: and: but no are given. No direct events or summaries are available after recent evidence window, so success claims cannot be quoted from the reviewed sources. Opportunity and risk both reflect a capital-intensive launch model with limited reviewed sources verification.

76
Univity
lowweak
Opp 5
Risk 4

Thesis: Best-supported opportunity in this sparse batch: the reviewed sources membership rationale says Univity raised $32M to build a European satellite network rivaling Starlink, which is a direct financing-and-buildout claim that can matter over a 1 year+ horizon if execution continues.

Why now: Why now is the claimed funding event and network build plan referenced in article ID: but the reviewed sources does not provide the article or detailed timestamp, so recency is only partially grounded.

Caveats: The key claim comes from membership rationale rather than available direct evidence. Article ID: is referenced without a. No evidence of downstream execution, contracts, launches, or adoption is present.

77
Vantor
lowweak
Opp 5
Risk 4

Thesis: The reviewed sources membership rationale describes potentially material traction: Vantor is described as having won a $70M NGA GEOINT platform contract, additional NGA Luno B contracts for orbital intelligence and AI change detection, and plans satellite constellation expansion, which would support a multi-quarter opportunity thesis if confirmed in article detail.

Why now: Why now is only moderate because the membership rationale references significant contracts via support references including: but the reviewed sources provide no or representative article detail for citation-quality corroboration. The forecast horizon of 1 year+ could fit contract conversion and constellation expansion if current, but recency cannot be validated from visible article rows.

Caveats: The contract and expansion claims appear only in membership rationale text; no representative article with is included. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0.

78
Albedo
lowweak
Opp 4
Risk 4

Thesis: Albedo has the clearest dated recency in the reviewed sources: an external article states the company announced plans on April 9 to send its second spacecraft and is preparing a second VLEO mission for 2027 launch, which suggests continued program progression over a 1 year+ horizon

Why now: Why now is stronger than for most names because the reviewed sources includes a dated representative article with April 9, 2026, stating that on April 9 Albedo announced plans for its second spacecraft and a 2027 launch for its second VLEO mission

Evidence
  • Representative article summary: Albedo announced plans April 9 to send its second spacecraft; summary says the company prepares a second VLEO mission for 2027 launch. spacenews.com

Caveats: The reviewed sources marks this as weak context only / supporting article context, not strong direct event evidence. Same article appears in multiple weak-context rows and should not be treated as independent confirmation.

79
Apogeo Space
lowweak
Opp 4
Risk 2

Thesis: Apogeo Space has moderate long-horizon opportunity on reviewed sources evidence because it is described as having a ground-station integration agreement and technical collaboration on CubeSat platforms, payloads, and joint missions, indicating active ecosystem positioning in space infrastructure and services.

Why now: The reviewed sources' membership rationale cites article: for the integration agreement and technical collaboration, but no article or direct evidence are included.

Caveats: Evidence is thin and article-level details are missing. Collaboration and integration agreements are weaker than revenue-bearing customer wins. Single-article support limits conviction.

80
Astranis
lowmedium
Opp 4
Risk 2

Thesis: Astranis has recent supporting article context indicating both contract relevance and financing support: it was included among companies awarded Space Force Andromeda contracts on April 8, 2026 and was reported to have raised a $300 million Series E on June 19, 2026, which supports a longer-horizon capacity and program participation thesis.

Why now: Recent dated context within the 90-day recent evidence window points to fresh financing and government program inclusion, both relevant for a 1 year+ horizon: Andromeda context on April 8, 2026 and funding context on June 19, 2026

Evidence
  • Published April 8, 2026: Space Force awarded 14 companies more than $1.8 billion in Andromeda contracts, and the listed companies included Astranis. defensedaily.com
  • Published June 19, 2026: Astranis raised a $300M Series E round and develops small communications satellites. spaceambition.substack.com

Caveats: Evidence is mainly supporting article context, which is weaker than direct event/fact evidence. An older 2025 article about a 2027 transportation deal exists, but it is outside the recent evidence window and not used as current proof.

Risk view

Showing rows 261-280 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
261
Axiom Space
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is present in the reviewed sources. Risk score remains low because absence of current evidence is not itself a negative thesis.

Why now: There is no within the recent evidence window catalyst in the available evidence. The only cited context is an older article with September 2, 2025, outside the 90-day evidence window

Caveats: Coverage after recent evidence window is effectively empty: evidence after recent evidence window is 0. Older supporting context exists but was excluded by the 90-day recent evidence window. No direct positive or negative evidence is available.

262
Axiom Space Inc.
lowweak
Opp 1
Risk 1

Thesis: No material risk thesis is supportable because the reviewed sources provide no direct negative evidence in the final evidence fields.

Why now: The phase2 rationale says Axiom was mentioned in connection with a lunar suit presentation and an orbital data center feature, but those article details are not surfaced in citable evidence here. Coverage data shows zero articles after recent evidence window and zero available evidence, so there is no current catalyst basis in the reviewed sources.

Caveats: Phase2 rationale is weaker than direct event/fact evidence. No dated current-state evidence is available in the scoring fields.

263
BAE Systems plc
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available for BAE Systems in this screen. Risk score stays low only because evidence is missing, not because the company is affirmatively de-risked.

Why now: Why-now is weak because the reviewed sources show no reviewed evidence after recent evidence window despite many articles considered, leaving no admissible dated evidence in the current output batch.

Caveats: Membership rationale references, and, but no article summaries or evidence are provided here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Broad-company membership in a cohort is not itself a directional opportunity thesis.

264
Baykar
lowweak
Opp 1
Risk 1

Thesis: No material negative thesis is supportable because the retained reviewed sources provide no direct negative evidence within the recent evidence window.

Why now: Why now is weak: there are no retained evidence after recent evidence window, and the reviewed sources' membership rationale is based only on weak indirect article context.

Caveats: Phase-2 membership rationale cites and says Fergani Space was described as 'Baykar affiliated,' but no article summary or quote is available in the retained reviewed sources for factual use here. The reviewed sources itself characterizes the evidence as weak, indirect article context.

265
Beyond Gravity
lowweak
Opp 1
Risk 1

Thesis: No material risk thesis can be supported from these reviewed sources because no direct negative evidence survived the 90-day recent evidence window.

Why now: There is no within the recent evidence window evidence in the reviewed sources for a current catalyst or state change; recency support is absent.

Caveats: The reviewed sources show 8 articles were considered but 0 article IDs remained after recent evidence filtering. Phase-2 membership rationale references: but no article summary or is provided in these reviewed sources, so it cannot be cited as factual support. Scores are kept near zero because direction must come from structured polarity/materiality evidence, which is absent.

266
Blackstar Orbital
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources offers no direct negative evidence, so there is no supportable risk thesis.

Why now: Membership rationale says Starfighters Space expanded technical interchange with Blackstar Orbital (SpaceDrone) in article: but relations are context only and no or direct evidence are provided.

Caveats: Relations marked context-only cannot be used as counterparty propagation evidence. No post-recent evidence window evidence are available. Referenced: has no in the reviewed sources.

267
Bluestaq
lowweak
Opp 0
Risk 1

Thesis: No material adverse evidence is shown either. The low risk score reflects absence of documented negative evidence, but the company remains unrankable on fundamentals from these reviewed sources.

Why now: There is no clear why-now catalyst because the only reference is an indirect executive-background mention, with no direct event, product, contract, or financing evidence available.

Caveats: No current evidence is provided for Indirect mention via an executive's prior role is not direct company evidence. Zero evidence available after recent evidence window.

268
BULL Co., Ltd.
lowweak
Opp 2
Risk 1

Thesis: No retained within the recent evidence window direct negative evidence is provided.

Why now: No within the recent evidence window evidence were retained, so there is no strong timing signal for a 1 year+ ranking beyond weak membership context.

Caveats: Membership rationale references articles and, but the reviewed sources does not provide or retained evidence. Potential commercial significance cannot be sized from the reviewed sources.

269
Calian Group Ltd.
lowweak
Opp 2
Risk 1

Thesis: No direct negative evidence is available, so there is no supported adverse thesis beyond normal uncertainty from lack of recent evidence.

Why now: Why now is weak because the reviewed sources retained no evidence after recent evidence window for Calian, so no current catalyst is evidenced.

Caveats: Reviewed evidence mentions: but provides no, preventing direct citation as scored evidence. No retained 90-day evidence. Opportunity case depends on uncited older context rather than current business-state confirmation.

270
Canada Rocket Company
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available in the reviewed sources within the recent evidence window, so there is no supported negative thesis beyond generic execution risk, which cannot be used without company-specific evidence.

Why now: No dated within the recent evidence window scoring evidence is available. The reviewed sources show zero reviewed evidence after recent evidence filtering, so recency-sensitive judgment is not possible from this screen.

Caveats: Phase-2 membership rationale references support article: but the article summary and evidence are not available here, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Absence of negative evidence is not positive evidence.

271
Canon Inc.
lowweak
Opp 1
Risk 1

Thesis: No direct negative evidence is available, so there is no reviewed sources basis for a material risk thesis.

Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 863 article IDs considered but 0 after recent evidence window and 0 evidence available after dedupe.

Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Described relevance is only incidental counterparty/customer context.

272
Capella Space
lowweak
Opp 1
Risk 1

Thesis: No direct negative evidence is retained either, so a risk thesis is not supported on this slice.

Why now: Why now is weak because only 2 articles were considered and none remained after the 90-day recent evidence window; current business-state evidence is absent.

Caveats: Duplicate/slice limitation noted in phase-2 rationale. No recent evidence window-qualified direct evidence. This reviewed sources specifically warns stronger Capella evidence may exist elsewhere, but it is not in this local reviewed sources and cannot be used.

273
China Aerospace Science and Technology Corporation
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources does not load any direct negative evidence within the 90-day recent evidence window, so no risk thesis is supported.

Why now: No current ranking evidence is available: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites contextual mention of CASC via article, but unavailable in reviewed sources.

Caveats: Only contextual mention is described in membership rationale. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources.

274
China Rocket
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources does not retain sufficient direct negative evidence for a risk thesis.

Why now: The membership rationale says Jielong 3 is by CASC subsidiary China Rocket and cites article, but support is described as only a brief article-context mention and no retained evidence row or is provided after recent evidence window.

Caveats: Support is explicitly called provisional single-article context in the reviewed sources. No retained evidence are available.

275
China Spacesat
lowweak
Opp 1
Risk 1

Thesis: There is no retained adverse evidence specific to China Spacesat, so a risk thesis is unsupported.

Why now: No within the recent evidence window catalyst or business-state change is documented. The reviewed sources show zero retained evidence after recent evidence window.

Caveats: Phase-2 rationale references: but no or retained article summary is provided. Support is described as provisional single-article context only. Coverage debug shows no retained evidence.

276
Chunghwa Telecom Co., Ltd.
lowweak
Opp 1
Risk 1

Thesis: No material adverse thesis is supportable from the retained reviewed sources evidence because there is no direct negative evidence after recent evidence window.

Why now: Why now is weak: the reviewed sources show zero retained evidence after recent evidence window, so there is no current catalyst or business-state confirmation in the evidence provided.

Caveats: Phase-2 membership rationale references: and says Astranis has new satellite projects with Chunghwa Telecom launching later in 2026, but no article summary or retained quoted evidence is included here, and relations are context-only unless separately policy-gated. Coverage after recent evidence window is empty for this company.

277
CITIC Group
lowweak
Opp 0
Risk 1

Thesis: No material direct negative evidence is available, but ambiguity and possible spurious matching elevate watchlist risk slightly.

Why now: There is no current catalyst. Despite 4,475 article IDs considered, the reviewed sources reports zero article IDs after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase2 rationale references article IDs: and: as context, but no were provided in the reviewed sources. Very large raw mention universe does not imply conviction or thesis attractiveness. Possible name/alias ambiguity is unresolved by the reviewed sources.

278
Citra Space Corp
lowweak
Opp 2
Risk 1

Thesis: No retained within the recent evidence window direct negative evidence is provided, so there is no basis for a strong risk thesis.

Why now: There is no usable within the recent evidence window article evidence available for ranking; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any current catalyst judgment would be speculative.

Caveats: Membership rationale references article, but the reviewed sources does not provide the article or retained ranking evidence inside the recent evidence window. Because direct evidence arrays are empty, the small positive score reflects only weak contextual possibility, not high-confidence attractiveness.

279
Clear Space
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is present. Ranking remains low on risk because the reviewed sources does not document a negative catalyst.

Why now: There is no strong why-now support because no evidence were available after recent evidence window; current operating or financing status is unconfirmed in the reviewed sources.

Caveats: No in-window evidence are available. Membership rationale itself notes the evidence is sparse and does not explicitly establish on-orbit servicing in these reviewed sources. Recency is unconfirmed.

280
Collins
lowweak
Opp 1
Risk 1

Thesis: Entity-identity ambiguity is the main risk in these reviewed sources; there is no available material adverse evidence specific to Collins after recent evidence filtering.

Why now: There is no usable timing evidence. Despite large article count, coverage data shows 0 articles after recent evidence window and 0 evidence after recent evidence window, and no are provided for cited support article ids or.

Caveats: High mention volume is not conviction and cannot substitute for company-specific evidence. The reviewed sources itself flags insufficiently established entity identity and role. No representative articles or are available for citation despite many articles considered.